Locations:
SearchAdvertisement
Diagnosis and treatment of MOG antibody-associated disease
Care guidelines have been crucial to progress in TBI care over the past 25 years
Mounting evidence of possible shared genetic predisposition
Recently launched first-of-kind study aims to address an unmet therapeutic need
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Biomarker promises a practical way to reduce misdiagnoses
AHA scientific statement offers best practices to improve care for high-risk populations
Relapse rates were lower with oral or infusion therapy after initial injectable DMT
No notable difference in reactions with two-hour infusion in ENSEMBLE PLUS substudy
We now have an expanded toolbox to extend survival and lessen treatment toxicity
Registry-based study is first to assess the issue in relation to cognition in epilepsy
Advertisement
Advertisement